Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.1.22 (
cystathionine beta-synthase
)
965
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cystathionine beta-synthase
(
CBS
) is a pyridoxal-phosphate-dependent enzyme that catalyzes a beta-replacement reaction in which the hydroxyl group of serine (L-Ser) is displaced by the thiol of homocysteine (L-Hcys) to form cystathionine (L-Cth) in the first step of the trans-sulfuration pathway. A new continuous assay for the forward reaction, employing cystathionine beta-lyase and
L-lactate dehydrogenase
as coupling enzymes, is described. It alleviates product inhibition by L-Cth and revealed that the values for (1.2 mM) and for substrate inhibition by L-Hcys ( = 2.0 mM) are lower than those previously reported. A continuous, 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB)-based assay for the
CBS
-catalyzed hydrolysis of L-Cth to L-Ser and L-Hcys provides a tool for investigation of the reverse reaction (k(catR) = 0.56 s(-)(1), = 0.083 mM). The (catR)/ versus pH profile of ytCBS is bell-shaped with a pH optimum of 8.3, and the pK(a) values for the acidic and basic limbs are 8.05 and 8.63, respectively. The latter is assigned to the alpha-amino group of L-Cth (pK(a) = 8.54). The internal aldimine of ytCBS remains protonated at pH < 11; therefore, the acidic pK(a) is assigned to an enzyme functionality that is not associated with the internal aldimine. K(eq) was determined directly and from the kinetic parameters, and the values are 0.61 and 1.2 microM, respectively.
...
PMID:Kinetics of the yeast cystathionine beta-synthase forward and reverse reactions: continuous assays and the equilibrium constant for the reaction. 1252 86
During infection, the common respiratory tract pathogen Streptococcus pneumoniae encounters several environmental conditions, such as upper respiratory tract, lung tissue, and blood stream, etc. In this study, we examined the effects of blood on S. pneumoniae protein expression using a combination of highly sensitive 2-dimensional electrophoresis (DE) and MALDI-TOF MS and/or LC/ESI-MS/MS. A comparison of expression profiles between the growth in THY medium and THY supplemented with blood allowed us to identify 7 spots, which increased or decreased two times or more compared with the control group: tyrosyl-tRNA synthetase, lactate oxidase, glutamyl-aminopeptidase,
L-lactate dehydrogenase
,
cysteine synthase
, ribose-phosphate pyrophosphokinase, and orotate phosphoribosyltransferase. This global approach can provide a better understanding of S. pneumoniae adaptation to its human host and a clue for its pathogenicity.
...
PMID:The effect of protein expression of Streptococcus pneumoniae by blood. 1712 5
Cystathionine beta-synthase
(
CBS
) catalyzes the pyridoxal-50-phosphate-dependent condensation of L-serine and L-homocysteine to form L-cystathionine in the first step of the transsulfuration pathway. Although effective expression systems for recombinant human
CBS
(hCBS) have been developed, they require multiple chromatographic steps as well as proteolytic cleavage to remove the fusion partner. Therefore, a series of five expression constructs, each incorporating a 6-His tag, were developed to enable the efficient purification of hCBS via immobilized metal ion affinity chromatography. Two of the constructs express hCBS in fusion with a protein partner, while the others bear only the affinity tag. The addition of an amino-terminal, 6-His tag, in the absence of a protein fusion partner and in the absence or presence ofa protease-cleavable linker, was found to be sufficient for the purification of soluble hCBS and resulted in enzyme with 86-91% heme saturation and with activity similar to that reported for other hCBS expression constructs. The continuous assay for L-Cth production, employing cystathionine beta-lyase and
L-lactate dehydrogenase
as coupling enzymes, was employed here for the first time to determine the steady-state kinetic parameters of hCBS, via global analysis, and revealed previously unreported substrate inhibition by L-Hcys (K(i)(L-HCYS) = 2.1 +/- 0.2 mM). The kinetic parameters for the hCBS-catalyzed hydrolysis of L-Cth toL-Ser and L-Hcys were also determined and the k(cat)/K(m)(L-CTH) of this reaction is only approximately 2-fold lower than the k(cat)/K(m)(L-SER) of the physiological, condensation reaction.
...
PMID:Kinetic characterization of recombinant human cystathionine beta-synthase purified from E. coli. 1901 Apr 20